TranS1 Inc. Announces Participation in Canaccord Genuity Musculoskeletal Conference
March 14, 2013 16:01 ET
|
Baxano Surgical, Inc.
RALEIGH, N.C., March 14, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it will participate in the Canaccord Genuity Musculoskeletal conference in March.
Ken Reali,...
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2012, Issues First Quarter 2013 Guidance
March 04, 2013 07:00 ET
|
Baxano Surgical, Inc.
- Fourth quarter revenues were $4.1 million -
- Net loss per share was $0.44 for the quarter –
- Excluding special items, net loss per share was $0.20 for the quarter* -
RALEIGH, N.C.,...
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment
March 04, 2013 07:00 ET
|
Baxano Surgical, Inc.
Conference Call to be Held on March 4, 2013 at 8:30 a.m. EST
Combination Adds Rapidly Growing Minimally Invasive Spinal Decompression Technology and Large Surgeon User Base
Baxano Shareholders...
TranS1 Inc. Announces Participation in Two Healthcare Conferences
February 21, 2013 16:25 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 21, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it will participate in two healthcare conferences in February and March, 2013.
Ken Reali, President...
TranS1 Inc. Schedules Fourth Quarter 2012 Results Conference Call for Monday, March 4, 2013
February 20, 2013 16:01 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 20, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release fourth quarter 2012 financial and operating results after market close on Monday,...
TranS1 Appoints Mark Stautberg to Board of Directors
February 19, 2013 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 19, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions...
TranS1 Inc. Announces Coverage Milestone
February 11, 2013 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 11, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the...
TranS1 Inc. Announces Preliminary Unaudited Fourth Quarter 2012 Revenue
January 14, 2013 07:00 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Jan. 14, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the...
TranS1 Inc. Announces Tentative Settlement With Office of Inspector General
December 27, 2012 16:01 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Dec. 27, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the...
TranS1 Inc. Announces Participation at the 2012 Piper Jaffray Healthcare Conference
November 14, 2012 16:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Nov. 14, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and...